Skip to search boxSkip to navigationSkip to main content

A transformed murine Leydig cell line expresses the ETA receptor subtype

  • Adviye Ergul
    ,
  • Marilyn K. Glassberg
    ,
  • Marc E. Freeman
    ,
  • David Puett(corresponding author)
*Corresponding author for this work
  • ,
  • University of Miami
    ,
  • Florida State University
    ,
  • University of Georgia
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

We recently demonstrated that transformed murine Leydig cells (MA-10) responded to endothelin-1 (ET-1) via increased steroidogenesis. This study addresses the endothelin receptor subtype present on this cell line and whether or not the cells produce ET-1. The expression of the preproendothelin-1 (PPET-1) gene was investigated by Northern blot analysis, and PPET-1 mRNA was found to be <0.2% of that present in pulmonary endothelial cells. The medium from MA-10 cells, maintained under serum-free conditions, was analyzed by radio-immunoassay to determine immunoreactive-ET-1 production and ET-1 levels were found to be below the sensitivity of the assay (<10 pg/ml). The data from competitive binding experiments with [125I]ET-1 and unlabeled ET-1, ET-3 and receptor subtype selective ligands yielded a single class of high affinity binding sites with ETA receptor subtype characteristics. The results of this study demonstrate that MA-10 cells possess the ETA receptor subtype but do not produce significant quantities of ET-1 under basal conditions.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 91-96 (6 pages)

Journal (Volume, Issue Number)

Molecular and Cellular Biochemistry (Volume 136, Issue 1)

Publication milestones

  • Published - 07/1994

Publication status

Published - 07/1994

ISSN

0300-8177

Publication IDs

  • Scopus: 0027994684
  • PubMed: 7854336

Publication metrics

Metrics

Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

Funding Details

FunderFunding number
NIDDK
R01DK033973